Call-On-Doc Review
Best for: Patients wanting fast, no-appointment branded GLP-1 access with pharmacy insurance use
Call-On-Doc is a large multi-condition online telehealth service (2M+ patients, 800k+ five-star reviews) offering a GLP-1 weight-loss program. It can prescribe branded GLP-1 medications including Wegovy, Ozempic, Mounjaro, Zepbound and Saxenda, with flat-rate visit pricing and no appointment needed; most visits are completed within two hours, seven days a week, including text consults. Care is delivered by board-certified providers and the service operates in all 50 states plus DC. Patients can use insurance at the pharmacy and an Rx savings card is available.
Medium confidence · Last verified 2026-06-04 · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Call-On-Doc is a solid telehealth option with balanced features and pricing.
Score Breakdown
✓ Pros
- •Prescribes branded GLP-1s (Wegovy, Ozempic, Mounjaro, Zepbound, Saxenda)
- •Available in all 50 states plus DC
- •Fast, no-appointment visits usually completed within two hours
- •Patients can use insurance at the pharmacy plus an Rx savings card
- •Large, well-reviewed platform (2M+ patients, 800k+ 5-star reviews)
✗ Cons
- •Specific visit fee and medication pricing not posted on homepage
- •Credit card required for the visit fee
- •Multi-condition focus rather than weight-loss specialist
- •Provider credentials described only generically
Ready to start with Call-On-Doc?
See current pricing and start your free consultation.
Sources & methodology
Our Call-On-Doc review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of June 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
Alternatives to Call-On-Doc
Editorial score · methodology
Bodybuilding Health+
Best for: fitness-brand compounded GLP-1 with hormone and performance programs
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Call-On-Doc?
See current pricing and start your free consultation.